GB HealthWatch Launches Nutritional Genomics Analysis within Digital Health Platform to Combat Coronary Heart Disease, Obesity and Type 2 Diabetes prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
Gene variants increase risk of clogged arteries futurity.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from futurity.org Daily Mail and Mail on Sunday newspapers.
Published: Mar 02, 2021
New Board appointments strengthen Tenax with world-class expertise in cardiovascular drug development, commercial strategy, and business development
New Directors will provide significant guidance as Tenax is poised to advance its two leading drug candidates into late-stage clinical testing
Transformational step as Tenax strengthens its positioning as a leading specialty pharmaceutical company focused on cardio-pulmonary therapeutics
a specialty pharmaceutical company focused on identifying and developing therapeutics that address cardio-pulmonary diseases with high unmet medical need, today announced the appointment of four new members to its board of directors: June Almenoff, MD, PhD, Michael Davidson, MD, Delcan Doogan, MD, and Stuart Rich, MD.
February 2, 2021
Tamar Haspel
THE WASHINGTON POST – There’s a lot of competition for the most contentious issue in weight loss, but I’d have to give the nod to ketogenic diets. Now a study about them sheds some interesting new light – although I’m not holding out hope for kumbaya.
First though, a brief overview of the theory of ketogenic diets. When you eat carbohydrates, your body processes them with insulin, which shuttles blood glucose into fat stores, leaving you hungry.
If you don’t eat many carbs, your body starts running on ketones, which your liver manufactures from fat – less hunger, less fat accumulation. Or that’s the theory, at any rate.